The inspection scope included 6 separate Biologics manufacturing units comprising 4 Drug Substance and 2 Drug Product manufacturing plants
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Accelerating sustainability in Indian pharma industry
Launch of 20 new medicines expected by 2030
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
Highly effective preservation solutions ensuring the safety and protection of personal care products
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
Subscribe To Our Newsletter & Stay Updated
